The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation (Q38966224)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 August 2014
edit
Language Label Description Also known as
English
The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation
scientific article published on 13 August 2014

    Statements

    The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation (English)
    Vipin Yadav
    Teresa F Burke
    Lysiane Huber
    Robert D Van Horn
    Youyan Zhang
    Sean G Buchanan
    Edward M Chan
    James J Starling
    Richard P Beckmann
    Sheng-Bin Peng
    13 August 2014
    2253-2263

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit